For instance, genetic ablation of IL1RL1 protected mice from developing experimental inflammatory bowel disease, and an antagonist of IL1RL1 could reduce the symptoms of colitis in these animals (Sedhom et al., 2013). This evidence concerns the gene IL1RL1 and colitis.